机译:Dabigatran逆转在胃肠道出血患者中的idarucizumab逆转
Leiden Univ Med Ctr Dept Thrombosis &
Hemostasis Albinusdreef 2 NL-2300 RC Leiden Netherlands;
Duke Univ Med Ctr Div Cardiol Durham NC 27710 USA;
Icahn Sch Med Mt Sinai Henry D Janowitz Div Gastroenterol New York NY 10029 USA;
Boehringer Ingelhe Pharmaceut Ridgefield CT USA;
Boehringer Ingelheim Int GmbH Ingelheim Germany;
Boehringer Ingelheim Int GmbH Ingelheim Germany;
Boehringer Ingelheim Int GmbH Ingelheim Germany;
Leiden Univ Med Ctr Dept Thrombosis &
Hemostasis Albinusdreef 2 NL-2300 RC Leiden Netherlands;
Thomas Jefferson Univ Emergency Med Philadelphia PA 19107 USA;
Leiden Univ Med Ctr Dept Thrombosis &
Hemostasis Albinusdreef 2 NL-2300 RC Leiden Netherlands;
atrial fibrillation; dabigatran; gastrointestinal hemorrhage; idarucizumab;
机译:Dabigatran逆转在胃肠道出血患者中的idarucizumab逆转
机译:在患有急性肾损伤的患者中使用idArcizumab逆转Dabigatran出血和凝血病。
机译:达比加群患者中伊达珠单抗胃肠道出血的逆转和腹膜后血肿的偶然发现
机译:Dabigatran逆转的PK / PD模型在非临床研究中的非临床研究和人类反应预测
机译:肝硬化患者的预端镜下特征,以区分上胃肠出血的潜在内窥镜介入病因
机译:急性肾损伤患者使用伊达珠单抗逆转达比加群出血和凝结病
机译:Dabigatran逆转在胃肠道出血患者中的idarucizumab逆转